Financials
Financial year 2025
Dr. Karl Dujardin from Roeselare, company number BE0862628720, closed financial year 2025 with a result of € 638,939 after tax. For that financial year Dr. Karl Dujardin recorded a gross margin of € 580,098 and equity of € 4 million. Compared with financial year 2024, the result moved from € 401,805 to € 638,939. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 26, 2026.
€ 4 million
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 638,939
▲ 59% vs 2024
Profit after tax over the fiscal year.
€ 109,611
▼ 85% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 87,750 paid out
14 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 5,127
▼ 96% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 520,046
▼ 21% vs 2024
€ 143,294 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 25,162
▼ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 126,600
▲ € 107,633 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 497,097 | € 393,888 | € 413,774 | € 580,098 | ▲ 40% |
| Profit after taxes | € 460,434 | € 284,542 | € 401,805 | € 638,939 | ▲ 59% |
| Equity | € 3,111,149 | € 3,206,832 | € 3,436,994 | € 3,988,183 | ▲ 16% |
| Total debts | € 678,666 | € 897,526 | € 888,015 | € 947,921 | ▲ 7% |
| Cash | € 1,052,599 | € 725,954 | € 740,267 | € 109,611 | ▼ 85% |
| Land & buildings | € 544,822 | € 821,370 | € 1,023,460 | € 1,000,161 | ▼ 2% |
| Retained profit | € 2,891,149 | € 2,986,832 | € 3,216,994 | € 3,768,183 | ▲ 17% |
| Dividend | € 271,777 | € 188,859 | € 171,643 | € 87,750 | ▼ 49% |
| Bank debt | € 284,878 | € 605,927 | € 660,699 | € 520,046 | ▼ 21% |
| Balance sheet total | € 3,789,815 | € 4,104,358 | € 4,325,009 | € 4,936,104 | ▲ 14% |
Key figures of Dr. Karl Dujardin, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Dr. Karl Dujardin?
What happened at Dr. Karl Dujardin in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 638,939 (▲ 59% vs 2024). Source: NBB ↗
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 460,434 profit in 2022 to € 638,939 profit in 2025.
Paid € 789,448 in corporate taxes since 2022.
Best year ever: 2025, with € 638,939 profit.
Paid out € 720,030 in dividends to the owners in total.
Management
Behind Dr. Karl Dujardin is Karl Dujardin. It owns 100% of Invest Dujardin itself.
Directors
According to the 2025 annual accounts
Karl Dujardin
Director
Establishments
Establishment units
Physical locations of this company
Meiboomlaan 126
8800 Roeselare
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0862.628.720
- VAT number
- BE 0862.628.720
- Registered office
- Meiboomlaan 126, 8800 Roeselare
- Names & denominations
- Dr. Karl Dujardin
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 January 2004
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Activiteiten van medisch specialisten
Overige onderwijsondersteunende dienstverlening